There are currently no published clinical trials evaluating the safety or efficacy of compounded GLP-1 ODTs
If you inadvertently left your vial out, the presence of this preservative might provide a thin layer of protection against microbial contamination, though it cannot stop the chemical breakdown of the peptide chain itself
SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) increase urinary glucose excretion, creating a glucose-rich environment in the genitourinary tract that promotes fungal overgrowth
Plan sponsors have struggled with managing the high costs of GLP-1s, with some restricting coverage or shifting coverage off pharmacy to the medical benefit to save costs
A key consideration is that weight regain is common once someone stops a GLP-1
If you notice any change in color or clarity from the time you first received the vial, it is best to consult your medical team before continuing your injections